摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid | 120236-27-3

中文名称
——
中文别名
——
英文名称
(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid
英文别名
(2S,3R)-aminomethyl-3-hydroxybutanoic acid;(2S,3R)-2-aminomethyl-3-hydroxybutyric acid;(2S,3R)-2-(aminomethyl)-3-hydroxybutanoic acid
(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid化学式
CAS
120236-27-3
化学式
C5H11NO3
mdl
——
分子量
133.147
InChiKey
WFRNRWHEMQWFRH-DMTCNVIQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    326.9±32.0 °C(Predicted)
  • 密度:
    1.237±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -3.7
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    83.6
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid 在 N-t-butyl-2-benzimidazolylsulfenamide 、 三苯基膦 作用下, 以 乙腈 为溶剂, 反应 1.0h, 以89%的产率得到(1'R,3S)-3-<1'-(hydroxy)ethyl>-2-azetidinone
    参考文献:
    名称:
    使用亚磺酰胺/三苯膦从β-氨基酸制备β-内酰胺的简便方法
    摘要:
    通过用N-烷基-2-苯并噻唑基亚磺酰胺和三苯基膦处理,β-,γ-和δ-氨基酸易于高产率地环化为相应的β-,γ-和δ-内酰胺。
    DOI:
    10.1016/0040-4039(95)00658-y
  • 作为产物:
    描述:
    (2S,3R)-2-[(苯甲酰基氨基)甲基]-3-羟基丁酸甲酯三乙胺 作用下, 以 12N-hydrochloric acid 、 甲苯乙腈 为溶剂, 以80%的产率得到(2S)-3-amino-2-((1R)-1-hydroxyethyl)propionic acid
    参考文献:
    名称:
    Method of preparing a derivative of optically active azetidin-2-one
    摘要:
    为制备化合物(1'R,3S)-3-(1'-三取代硅氧基乙基)吖啶-2-酮,(2S,3R)-2-氨甲基-3-羟基丁酸与一种来自硫酰氯、氯化氢和对甲苯磺酸组合的至少一种化合物在醇的存在下发生反应,从而获得相应酯的盐。该盐在金属催化剂的存在下与三取代硅烷发生反应,从而保护酯的羟基,然后与碱发生反应,从而获得(2S,3R)-2-氨甲基-3-(三取代硅氧基)丁酸酯。随后,在格氏试剂或金属酰胺的存在下将酯转化为内酰胺,从而获得(1'R,3S)-3-(1'-三取代硅氧基乙基)吖啶-2-酮。该化合物为制备β-内酰胺类抗菌药物如头孢菌素类药物提供了有用的基础。
    公开号:
    US05712388A1
点击查看最新优质反应信息

文献信息

  • Process for preparing (1'R,3S)-3-(1'-hydroxyethyl)-azetidin-2-one and
    申请人:Takasago International Corporation
    公开号:US05204461A1
    公开(公告)日:1993-04-20
    A process for preparing (1'R,3S)-3-(1'-hydroxyethyl)-azetidin-2-one or a derivative thereof represented by formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or a hydroxyl-protective group, is disclosed, comprising reacting (2S,3R)-2-aminomethyl-3-hydroxybutyric acid or a derivative thereof represented by formula (II): ##STR2## wherein R.sup.1 is as defined above, with a sulfenamide represented by formula (III): ##STR3## wherein R.sup.2 represents ##STR4## and R.sup.3 and R.sup.4 each represent a hydrogen atom or a cyclic or acyclic hydrocarbon group, provided that they do not simultaneously represent a hydrogen atom, or R.sup.3 and R.sup.4 are taken together with the adjacent nitrogen atom to form a heterocyclic group, and triphenylphosphine. The reaction yield is high, and the sulfenamide (III) used as a lactamization reagent is cheap and can be recovered after the reaction.
    揭示了一种制备(1'R,3S)-3-(1'-羟乙基)-吖啶-2-酮或其衍生物的方法,其表示为式(I):其中R.sup.1代表氢原子或羟基保护基,包括将(2S,3R)-2-氨甲基-3-羟基丁酸或其衍生物(II式)与一种代表为式(III)的磺胺酰胺反应,其中R.sup.2代表...和R.sup.3和R.sup.4分别代表氢原子或环状或非环状碳氢基团,前提是它们不同时代表氢原子,或R.sup.3和R.sup.4与相邻的氮原子一起形成杂环基团,以及三苯基膦。 反应产率高,作为内酰胺化试剂使用的磺胺酰胺(III)便宜且可在反应后回收。
  • Ruthenium catalyzed process for preparing 4-acetoxyazetidinones
    申请人:Takasago International Corporation
    公开号:US05204460A1
    公开(公告)日:1993-04-20
    A simplified process for preparing 4-acetoxyazetidinones of formula (I): ##STR1## wherein Z is a hydrogen atom, a lower alkyl group or a hydroxyethyl group which may or may not be protected is disclosed. According to the invention, azetidinones of formula (II): ##STR2## wherein Z has the same meaning as defined above and Y is a hydrogen atom or a carboxyl group is reacted with acetic acid and an oxidizing agent in the presence of a ruthenium compound represented by the formula [Ru(B).sub.2 (L)].sub.m wherein B is Cl, Br or l, m is a positive integer, and L is 1,5-cyclooctadiene, norbornadiene, cycloheptatriene, cyclooctatetraene or benzene which may or may not have a lower alkyl group as a substituent, as a catalyst.
    本发明公开了一种制备式(I)的4-乙酰氧基氮杂环丁酮的简化过程:##STR1## 其中Z是氢原子,低级烷基或羟乙基基团,可以或不可以被保护。根据本发明,式(II)的氮杂环丁酮:##STR2## 其中Z具有上述定义的相同含义,Y是氢原子或羧基团,与乙酸和氧化剂在铑化合物的存在下反应,所述铑化合物由式[Ru(B).sub.2 (L)].sub.m表示,其中B为Cl、Br或l,m为正整数,L为1,5-环辛二烯、去氢萘二烯、环庚三烯、环辛四烯或苯,可以或不可以有低级烷基基团作为取代基,作为催化剂。
  • Process for the manufacture of 4-acyloxy-3-hydroxyethyl-azetidinones
    申请人:Ciba-Geigy Corporation
    公开号:US05274188A1
    公开(公告)日:1993-12-28
    The invention relates to a novel process for the manufacture of (3R,1'R)-4-acyloxy-3-(1'-hydroxyethyl)-2-azetidinones of formula ##STR1## in which R.sup.1 represents lower alkyl or aryl, by enantioselective reduction of the carbonyl group in a suitable .alpha.-acylaminomethyl-acetoacetic acid ester, cyclisation of the resulting .alpha.-acylaminomethyl-.beta.-hydroxybutyric acid ester to a 5,6-dihydro-1,3,4H-oxazine with inversion of the carbon atom carrying the hydroxy group, equilibration to form the preferred trans-substituted dihydrooxazine, recleaving to form the configuratively uniform .alpha.-aminomethyl-.beta.-hydroxybutyric acid, ring-closure to form the .beta.-lactam and oxidative acylation at C(4) of the .beta.-lactam. Compounds of formula I can be used as starting materials for the manufacture of .beta.-lactam antibiotics. The invention relates also to novel intermediates.
    本发明涉及一种新型工艺,用于制造式为##STR1##的(3R,1'R)-4-酰氧基-3-(1'-羟乙基)-2-氮杂环己酮,其中R1代表较低的烷基或芳基,通过对适宜的α-酰氨甲基-乙酰乙酸酯中的羰基基团进行对映选择性还原,将得到的α-酰氨甲基-β-羟基丁酸酯环化成带有羟基的5,6-二氢-1,3,4H-噁嗪,翻转携带羟基的碳原子,平衡形成优选的反式取代二氢噁嗪,再次裂解形成构型一致的α-氨甲基-β-羟基丁酸,环合成β-内酰胺,氧化酰化β-内酰胺的C(4)。式I的化合物可用作β-内酰胺类抗生素的原料。本发明还涉及新型中间体。
  • A convenient preparative method for β-lactams from β-amino acids using sulfenamide/triphenylphosphine
    作者:Toshiyuki Murayama、Toyohiko Kobayashi、Takashi Miura
    DOI:10.1016/0040-4039(95)00658-y
    日期:1995.5
    β-, γ-, and δ-Amino acids were easily cyclized in high yields to corresponding β-, γ-, and δ-lactams by treatment with N-alkyl-2-benzothiazolylsulfenamide and triphenylphosphine.
    通过用N-烷基-2-苯并噻唑基亚磺酰胺和三苯基膦处理,β-,γ-和δ-氨基酸易于高产率地环化为相应的β-,γ-和δ-内酰胺。
  • Method of preparing a derivative of optically active azetidin-2-one
    申请人:Takasago International Corporation
    公开号:US05712388A1
    公开(公告)日:1998-01-27
    To prepare the compound (1'R,3S)-3-(1'-tri-substituted silyloxyethyl)azetidin-2-one, (2S,3R)-2-aminomethyl-3-hydroxybutyric acid is reacted with an alcohol in the presence of at least one compound chosen from the group consisting of thionyl chloride, hydrogen chloride and p-toluene sulfonic acid, thereby obtaining a salt of the corresponding ester. The salt is reacted with a tri-substituted silane in the presence of a metallic catalyst, thereby protecting the hydroxy group of the ester and then reacted with a base, thereby obtaining an ester of (2S,3R)-2-aminomethyl-3-(tri-substituted silyloxy)butyric acid. Subsequently, the ester is transformed into lactam in the presence of a Grignard reagent or a metal amide, thereby obtaining (1'R,3S)-3-(1'-tri-substituted silyloxyethyl)azetidin-2-one. This compound provides a useful base for preparing .beta.-lactam type antimicrobial agents such as carbapenem type agents.
    为制备化合物(1'R,3S)-3-(1'-三取代硅氧基乙基)吖啶-2-酮,(2S,3R)-2-氨甲基-3-羟基丁酸与一种来自硫酰氯、氯化氢和对甲苯磺酸组合的至少一种化合物在醇的存在下发生反应,从而获得相应酯的盐。该盐在金属催化剂的存在下与三取代硅烷发生反应,从而保护酯的羟基,然后与碱发生反应,从而获得(2S,3R)-2-氨甲基-3-(三取代硅氧基)丁酸酯。随后,在格氏试剂或金属酰胺的存在下将酯转化为内酰胺,从而获得(1'R,3S)-3-(1'-三取代硅氧基乙基)吖啶-2-酮。该化合物为制备β-内酰胺类抗菌药物如头孢菌素类药物提供了有用的基础。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物